Free Trial

GH Research (GHRS) Financials

GH Research logo
$11.17 -0.10 (-0.89%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$11.07 -0.10 (-0.90%)
As of 05/23/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for GH Research

Annual Income Statements for GH Research

This table shows GH Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Income / (Loss) Attributable to Common Shareholders
-39 -36 -22 -9.20 -0.45 -0.31
Consolidated Net Income / (Loss)
-39 -36 -22 -9.20 -0.45 -0.31
Net Income / (Loss) Continuing Operations
-39 -36 -22 -9.20 -0.45 -0.31
Total Pre-Tax Income
-39 -36 -22 -9.20 -0.45 -0.31
Total Operating Income
-50 -41 -31 -15 -0.45 -0.31
Total Gross Profit
0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
50 41 31 15 0.45 0.31
Selling, General & Admin Expense
15 11 10 6.55 0.11 0.01
Research & Development Expense
35 30 20 8.55 0.34 0.30
Total Other Income / (Expense), net
11 5.63 8.22 5.90 0.00 0.00
Interest Expense
0.72 0.72 0.12 0.01 - -
Interest & Investment Income
9.87 8.98 1.17 0.00 - -
Other Income / (Expense), net
2.13 -2.62 7.18 5.91 0.00 0.00
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($0.75) ($0.68) ($0.43) ($0.21) ($0.02) ($0.01)
Weighted Average Basic Shares Outstanding
52.03M 52.03M 52.02M 52.02M - -
Diluted Earnings per Share
($0.75) ($0.68) ($0.43) ($0.21) ($0.02) ($0.01)
Weighted Average Diluted Shares Outstanding
52.03M 52.03M 52.02M 52.02M - -
Weighted Average Basic & Diluted Shares Outstanding
52.03M 52.03M 52.02M 52.02M - -

Quarterly Income Statements for GH Research

No quarterly income statements for GH Research are available.


Annual Cash Flow Statements for GH Research

This table details how cash moves in and out of GH Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Change in Cash & Equivalents
23 -88 -111 271 5.17 0.51
Net Cash From Operating Activities
22 -33 -26 -15 -0.33 -0.29
Net Cash From Continuing Operating Activities
22 -26 -25 -15 -0.33 -0.29
Net Income / (Loss) Continuing Operations
-39 -36 -22 -9.20 -0.45 -0.31
Consolidated Net Income / (Loss)
-39 -36 -22 -9.20 -0.45 -0.31
Depreciation Expense
0.32 0.32 0.05 0.02 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
61 4.91 -3.22 -6.09 0.12 0.02
Net Cash From Investing Activities
-0.05 -54 -85 -0.10 0.00 0.00
Net Cash From Continuing Investing Activities
-0.05 -54 -85 -0.10 0.00 0.00
Purchase of Property, Plant & Equipment
-0.05 -0.10 -0.07 -0.10 0.00 0.00
Net Cash From Financing Activities
0.00 -0.20 0.00 286 5.50 0.80
Net Cash From Continuing Financing Activities
0.00 -0.20 0.00 286 5.50 0.80

Quarterly Cash Flow Statements for GH Research

No quarterly cash flow statements for GH Research are available.


Annual Balance Sheets for GH Research

This table presents GH Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Total Assets
188 226 254 280 5.91
Total Current Assets
154 164 169 280 5.91
Cash & Equivalents
101 78 166 277 5.90
Other Current Assets
4.90 2.53 2.59 3.07 0.02
Other Current Nonoperating Assets
19 56 0.00 - -
Plant, Property, & Equipment, net
0.75 1.07 0.10 0.00 0.00
Plant, Property & Equipment, gross
0.75 1.07 0.10 - 0.00
Total Noncurrent Assets
0.00 0.00 0.00 0.08 0.00
Total Liabilities & Shareholders' Equity
188 226 254 280 5.91
Total Liabilities
9.32 7.33 4.55 2.75 0.25
Total Current Liabilities
8.95 6.70 4.55 2.75 0.25
Accounts Payable
3.74 3.49 1.87 0.88 0.00
Other Current Liabilities
5.21 3.21 2.68 1.87 0.25
Total Noncurrent Liabilities
0.37 0.63 0.00 0.00 0.00
Capital Lease Obligations
0.37 0.63 0.00 - -
Total Equity & Noncontrolling Interests
179 219 250 277 5.67
Total Preferred & Common Equity
179 219 250 277 5.67
Total Common Equity
179 219 250 277 5.67
Common Stock
293 293 293 1.30 6.30
Retained Earnings
-106 -68 -32 -10 -0.84
Other Equity Adjustments
-7.37 -5.86 -10 286 0.20

Quarterly Balance Sheets for GH Research

No quarterly balance sheets for GH Research are available.


Annual Metrics And Ratios for GH Research

This table displays calculated financial ratios and metrics derived from GH Research's official financial filings.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Growth Metrics
- - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-11.83% -83.47% -154.32% -1,956.95% -43.87% 0.00%
EBIT Growth
-9.90% -87.54% -154.30% -1,961.21% -43.87% 0.00%
NOPAT Growth
-22.05% -34.92% -102.34% -3,285.65% -43.87% 0.00%
Net Income Growth
-9.48% -58.47% -144.03% -1,963.23% -43.87% 0.00%
EPS Growth
-10.29% -58.14% -104.76% -1,212.50% -45.45% 0.00%
Operating Cash Flow Growth
167.22% -27.24% -71.43% -4,531.21% -14.19% 0.00%
Free Cash Flow Firm Growth
-26.80% -44.39% -70.80% -13,359.13% 0.00% 0.00%
Invested Capital Growth
-6.48% -66.56% -566.92% 274.24% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
80.86% 81.17% 96.06% 100.10% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-19.58% -15.18% -8.52% -6.51% -7.87% 0.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -2,806.52% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-19.58% -15.18% -8.52% -6.51% -7.87% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-21.77% -16.25% -8.99% -3.32% -7.87% 0.00%
Net Operating Profit after Tax (NOPAT)
-35 -29 -21 -11 -0.31 -0.22
NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-1.85% -2.84% -0.40% 0.97% -4.54% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
-19.64% -13.14% -8.56% - - -
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-48 -44 -23 -9.19 -0.45 -0.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-48 -43 -23 -9.17 -0.45 -0.31
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
2.04 1.38 2.02 0.84 28.24 0.00
Price to Tangible Book Value (P/TBV)
2.04 1.38 2.02 0.84 28.24 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
11.77 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.02 -1.01 -1.00 -1.00 -1.04 0.00
Leverage Ratio
1.04 1.03 1.01 1.01 1.04 0.00
Compound Leverage Factor
0.84 0.83 0.97 1.01 1.04 0.00
Debt to Total Capital
0.21% 0.29% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.21% 0.29% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.79% 99.71% 100.00% 100.00% 100.00% 0.00%
Debt to EBITDA
-0.01 -0.01 0.00 0.00 0.00 0.00
Net Debt to EBITDA
2.10 1.82 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
-0.01 -0.01 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.01 -0.02 0.00 0.00 0.00 0.00
Net Debt to NOPAT
2.85 2.70 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
-0.01 -0.02 0.00 0.00 0.00 0.00
Altman Z-Score
22.73 24.47 67.03 51.95 390.95 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
17.23 24.49 37.07 101.80 24.03 0.00
Quick Ratio
11.26 11.70 36.51 100.68 23.96 0.00
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
-35 -28 -19 -11 -0.08 0.00
Operating Cash Flow to CapEx
45,728.57% -33,336.00% -39,102.99% -14,695.19% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-48.84 -38.20 -155.49 -1,244.22 0.00 0.00
Operating Cash Flow to Interest Expense
31.25 -46.11 -213.00 -1,698.11 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
31.18 -46.25 -213.54 -1,709.67 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
-3.30 -3.10 -1.86 0.40 -0.23 0.00
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
-0.20 -1.24 -2.26 0.63 -0.23 0.00
Enterprise Value (EV)
264 224 340 -43 154 0.00
Market Capitalization
364 302 506 233 160 160
Book Value per Share
$3.44 $4.21 $4.80 $5.33 $0.57 $0.00
Tangible Book Value per Share
$3.44 $4.21 $4.80 $5.33 $0.57 $0.00
Total Capital
179 220 250 277 5.67 0.00
Total Debt
0.37 0.63 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.37 0.63 0.00 0.00 0.00 0.00
Net Debt
-100 -78 -166 -277 -5.90 0.00
Capital Expenditures (CapEx)
0.05 0.10 0.07 0.10 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
44 79 -1.96 0.32 -0.23 0.00
Debt-free Net Working Capital (DFNWC)
145 157 164 277 5.67 0.00
Net Working Capital (NWC)
145 157 164 277 5.67 0.00
Net Nonoperating Expense (NNE)
3.74 6.73 1.07 -1.37 0.13 0.09
Net Nonoperating Obligations (NNO)
-182 -222 -252 -277 -5.90 0.00
Total Depreciation and Amortization (D&A)
0.32 1.04 0.05 0.02 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
($0.75) ($0.68) $0.00 ($0.21) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
52.03M 52.03M 0.00 52.02M 0.00 0.00
Adjusted Diluted Earnings per Share
($0.75) ($0.68) $0.00 ($0.21) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
52.03M 52.03M 0.00 52.02M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
52.03M 52.03M 0.00 52.02M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-35 -29 -21 -11 -0.31 -0.22
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-67.20 -60.64 -190.07 -1,021.44 0.00 0.00
NOPAT to Interest Expense
-49.12 -39.91 -173.88 -1,174.44 0.00 0.00
EBIT Less CapEx to Interest Expense
-67.27 -60.78 -190.61 -1,033.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-49.19 -40.05 -174.43 -1,186.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% -247.26% 0.00% 0.00%

Quarterly Metrics And Ratios for GH Research

No quarterly metrics and ratios for GH Research are available.


Frequently Asked Questions About GH Research's Financials

When does GH Research's fiscal year end?

According to the most recent income statement we have on file, GH Research's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has GH Research's net income changed over the last 5 years?

GH Research's net income appears to be on an upward trend, with a most recent value of -$38.96 million in 2024, rising from -$310 thousand in 2019. The previous period was -$35.59 million in 2023. See GH Research's forecast for analyst expectations on what’s next for the company.

What is GH Research's operating income?
GH Research's total operating income in 2024 was -$50.31 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $50.31 million
How has GH Research revenue changed over the last 5 years?

Over the last 5 years, GH Research's total revenue changed from $0.00 in 2019 to $0.00 in 2024, a change of 0.0%.

How much debt does GH Research have?

GH Research's total liabilities were at $9.32 million at the end of 2024, a 27.1% increase from 2023, and a 3,689.4% increase since 2020.

How much cash does GH Research have?

In the past 4 years, GH Research's cash and equivalents has ranged from $5.90 million in 2020 to $276.78 million in 2021, and is currently $100.79 million as of their latest financial filing in 2024.

How has GH Research's book value per share changed over the last 5 years?

Over the last 5 years, GH Research's book value per share changed from 0.00 in 2019 to 3.44 in 2024, a change of 344.0%.



This page (NASDAQ:GHRS) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners